02.18.22
Governments around the world have withheld access to life-changing medications for people with cystic fibrosis (CF) for years in the name of being hawkish on drug pricing. These countries allow bureaucrats to dictate which drugs are “worth it” but do so based on demonstrably flawed calculations of value. Patient communities must hold them accountable; their bad math and delay tactics cost lives and health.